from
$39.95Buy Sexual Health Peptides
Sale
Sale
Shop Sexual Health Peptides from a Leading Research Supplier
Healius Peptides supplies research peptides for sexual function, libido, and reproductive endocrinology studies to over 30,000 researchers across the US, UK, EU, Canada, Australia, and New Zealand. Every vial is third-party lab-tested to at least 99% purity, shipped with a matched Certificate of Analysis, and dispatched same-day on all orders placed before the cut-off. Shipping is free on orders over the qualifying threshold, and our 4.7-star average rating reflects what returning researchers already know: consistent purity, fast fulfillment, and compliant handling from a leading research peptide supplier.
The Healius sexual health peptide catalog covers three compounds across two mechanistic classes: melanocortin receptor activation (PT-141 and Melanotan 2 for central nervous system libido research) and hypothalamic GnRH axis signaling (Kisspeptin-10 for reproductive endocrinology studies). Every product on this page is sold strictly for laboratory research and in vitro use, is not for human or veterinary administration, and ships with full RUO labeling.
Peptides for Sexual Health and Libido: What Researchers Are Studying
Sexual function research has identified two primary peptide-accessible pathways: the melanocortin receptor system in the central nervous system and the hypothalamic GnRH (gonadotropin-releasing hormone) signaling axis that governs reproductive endocrinology. Both pathways have been the subject of published research using synthetic peptides, and the three compounds Healius supplies each interact with these systems through different receptor mechanisms.
What makes peptide-based sexual health research distinct from traditional pharmacological approaches is the pathway specificity. Where conventional compounds in this research space tend to act on peripheral vascular mechanisms, the peptides below target central nervous system signaling. Published research has investigated this distinction because centrally mediated sexual function operates upstream of peripheral responses and may influence dimensions of sexual behavior that peripheral vasodilators do not reach.
All three compounds are tested under strict US and UK quality control measures, verified to exceed 99% purity by HPLC, and backed by independent third-party analysis with a batch-specific Certificate of Analysis.
Sexual Health Peptides by Research Pathway
PT-141 (Bremelanotide) is a synthetic melanocortin receptor agonist derived from Melanotan 2 but modified to remove the pigmentation-related activity. PT-141 acts primarily on MC3R and MC4R receptors in the hypothalamus, and published research has investigated its effects on sexual arousal and desire responses in both male and female experimental models. Its mechanism is entirely central rather than peripheral, which has made it a focus of research examining how hypothalamic melanocortin signaling influences sexual behavior independently of vascular function. For researchers studying the neurological basis of sexual response, PT-141 is the most targeted compound available because it isolates the melanocortin pathway without the broader receptor profile of its parent compound MT2.
Kisspeptin-10 is a truncated form of the kisspeptin peptide that acts on the KISS1R (GPR54) receptor in the hypothalamus. Kisspeptin signaling is the primary trigger for GnRH secretion, which in turn drives the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the pituitary. Published research has examined Kisspeptin-10 for its effects on reproductive hormone cascades, gonadotropin pulsatility, and sexual arousal responses in human research models. Its position at the very top of the reproductive hormone axis makes it a uniquely positioned research tool for investigators studying how hypothalamic signaling governs downstream sexual and reproductive function.
Melanotan 2 (MT2) appears in both this category and our Cosmetic Peptides category because its broad melanocortin receptor profile spans pigmentation and sexual function research. MT2 activates MC1R non-selectively, and the MC3R/MC4R activation that drives its relevance to sexual health research is the same mechanism from which PT-141 was originally derived. Published studies have documented MT2’s effects on sexual arousal responses as a secondary research endpoint alongside its melanogenesis activity. Researchers who need both pigmentation and sexual function data from a single compound may find MT2 relevant. In contrast, those who need isolated sexual function signaling without the pigmentation component tend to prefer PT-141.
Best Peptides for Sexual Health Research: Choosing the Right Compound
Three compounds, two pathways. The choice depends on which aspect of sexual function your research is designed to investigate.
If your research targets melanocortin-mediated sexual arousal without pigmentation effects, PT-141 is the most focused tool. It was specifically engineered to isolate the MC3R/MC4R sexual function signaling from MT2’s broader receptor profile.
If your research targets the reproductive hormone axis and GnRH-driven sexual function, Kisspeptin-10 operates through an entirely separate receptor system (KISS1R) from the melanocortin peptides. It sits at the apex of the GnRH-LH-FSH cascade and is the right choice for studies examining how upstream hypothalamic signaling governs reproductive and sexual endocrinology.
If your research examines melanocortin receptor effects across both pigmentation and sexual function, MT2’s non-selective receptor profile gives you data on both pathways from a single compound. Researchers who need to isolate the sexual function component specifically should consider PT-141 instead.
Our research support team can discuss specifications and published references for all three compounds if you need help matching one to your protocol.
Buy Peptides for Libido Research with Verified 99% Purity.
Sexual health research protocols demand the same peptide quality as any other biological investigation. Impurities or sequence inaccuracies will produce off-target receptor activation and confound your results. Every compound Healius supplies meets the same rigorous quality bar regardless of category.
99%+ purity on all three compounds. HPLC and mass spectrometry verify purity, sequence accuracy, and molecular weight on every batch we produce.
Third-party laboratory verification. Independent external analysis confirms our internal results. The combined data ships as a batch-specific Certificate of Analysis with every order.
Pharmaceutical-grade quality systems. Testing, quality control, and fulfillment across our US and UK operations follow GMP and ISO 9001:2015 standards.
In stock, same-day dispatch. All three sexual health peptides ship on orders confirmed before 2 pm with tracked delivery to the US, UK, EU, and Australia.
Reconstitution guidance. Our Reconstitution Calculator handles dilution math for all three compounds, and our Reconstitution and Storage Guide covers preparation and stability for each one.
Browse All Sexual Health Peptides
Frequently Asked Questions
Sexual health peptides are synthetic compounds studied in published research for their effects on sexual function, arousal, and reproductive hormone signaling. They act through central nervous system pathways, primarily melanocortin receptors (MC3R, MC4R) and the kisspeptin-GnRH reproductive axis, rather than peripheral vascular mechanisms. All sexual health peptides sold by Healius Peptides are for in vitro research use only.
PT-141 (bremelanotide) is a synthetic melanocortin receptor agonist that activates MC3R and MC4R receptors in the hypothalamus. Published research has investigated its effects on sexual arousal and desire responses in both male and female experimental models. It was derived from Melanotan 2 but modified to remove melanogenesis-related activity, making it specific to the sexual function pathway within the melanocortin system.
PT-141 was engineered from MT2 to isolate the MC3R/MC4R sexual function signaling without the MC1R-driven pigmentation effects. MT2 activates melanocortin receptors non-selectively, meaning it influences both pigmentation and sexual function pathways simultaneously. Researchers who need clean sexual function data without pigmentation as a confounding variable use PT-141. Researchers studying the broader melanocortin receptor system across multiple endpoints may prefer MT2.
Kisspeptin-10 operates through an entirely different receptor system (KISS1R) from PT-141 and MT2 (melanocortin receptors). Kisspeptin signaling triggers GnRH release from the hypothalamus, which drives the LH and FSH cascade governing reproductive hormone production. It addresses sexual and reproductive function at the hormonal axis level rather than through melanocortin-mediated arousal pathways. The two systems are independent, and the choice between them depends on which biological pathway your research is investigating.
Yes. PT-141 has been the subject of published research examining sexual arousal and desire responses in female models. Its mechanism acts through hypothalamic melanocortin receptors, which are present and functional regardless of sex. Kisspeptin-10 has also been studied in female reproductive endocrinology research through its effects on the GnRH-LH-FSH axis. Both compounds are relevant to female sexual function and reproductive research.
No. Drugs like sildenafil (Viagra) act on peripheral vascular mechanisms by inhibiting PDE5 to increase blood flow. PT-141 and MT2 act centrally through melanocortin receptors in the hypothalamus, and Kisspeptin-10 acts on the hypothalamic GnRH axis. The mechanisms are fundamentally different: vascular drugs target blood flow at the tissue level, while these peptides target neural and hormonal signaling in the brain. All Healius products are research compounds sold for in vitro use only, not pharmaceutical drugs.
All three compounds exceed 99% purity verified by HPLC, with molecular weight and sequence accuracy confirmed by mass spectrometry. Every batch undergoes independent third-party laboratory verification, and the results are documented in a batch-specific Certificate of Analysis.
Store unopened lyophilized vials at -20 °C for long-term storage or 2-8 °C for short-term use. Reconstituted solutions should be kept at 2-8 °C and used within the stability window noted on each product page. Avoid freeze-thaw cycling. Compound-specific preparation details are available in our Reconstitution and Storage Guide.
Kisspeptin-10 has become a focus of published research into female reproductive endocrinology because it sits at the top of the GnRH-LH-FSH axis. Research groups have studied kisspeptin signaling in models of hypothalamic amenorrhea, perimenopausal hormone transition, and functional infertility, where the upstream GnRH pulse generator appears dysregulated. Reddit discussions in r/Menopause and r/PCOS frequently surface kisspeptin as a research-stage compound of interest because it acts further upstream than conventional hormone replacement protocols. Healius Peptides supplies Kisspeptin-10 strictly as a research-grade compound for in vitro laboratory use, not as a clinical treatment, and the published evidence base is still emerging.
PT-141 and Kisspeptin-10 operate through entirely separate receptor systems, so combination studies have been published examining both pathways simultaneously. PT-141 acts on melanocortin receptors (MC3R and MC4R) in the hypothalamus, while Kisspeptin-10 acts on KISS1R to drive GnRH release and the downstream LH and FSH cascade. Researchers designing combination protocols typically separate the two compounds by mechanism of action and measure distinct endpoints: arousal and desire responses for PT-141, reproductive hormone output for Kisspeptin-10. Both are sold strictly for in vitro research use.
No. All three compounds in this category are supplied as lyophilized powders for reconstitution and in vitro research use. Oral bioavailability of peptides in this class is generally limited by gastrointestinal degradation, which is why published research protocols work with reconstituted solutions rather than oral formulations. If an oral research formulation is essential for your protocol, contact our research support team through the Bulk page, and we can advise on what is available.
No. All Healius Peptides products are sold for in vitro research use only. Products must not be used in human or animal trials, administered to humans or animals, or supplied to any third party for human investigational use.
Join 35,000+ researchers
Subscriber-only pricing, new peptide drops, restock alerts, and fresh lab data delivered before anyone else.